The Big Day for Neuronetics

An FDA advisory panel will be reviewing Neuronetics' transcranial magnetic stimulation device today. Their recommendation will likely be followed by the FDA in either approving the treatment for depression or not. As soon as I see anything regarding the panel's decision, I'll let you know.